How did these equity grants affect J. Dean Mitchell’s Praxis (PRAX) share holdings?

After the grant of 1,371 restricted stock units reported in Table 1, Mitchell directly holds 18,622 shares of Praxis common stock. The 648 stock options are separate derivative securities that provide potential future ownership upon exercise, subject to vesting and expiration terms.

Praxis director receives RSU and option grants

Praxis Precision Medicines director J. Dean Mitchell received equity awards as part of his compensation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Praxis Precision Medicines director J. Dean Mitchell received equity awards as part of his compensation. He was granted 1,371 restricted stock units, each representing a right to receive one share of common stock, vesting in a single installment on the earlier of June 10, 2027 or the 2027 annual stockholder meeting.

Mitchell was also granted stock options for 648 shares of common stock at an exercise price of $240.66 per share, vesting in twelve equal monthly installments starting July 10, 2026 and ending on the earlier of June 10, 2027 or the 2027 annual meeting. Following these awards, he directly holds 18,622 common shares.

Insider Trade Summary

Grant/Award: 2,019 shares

Grant/Award 2 txns

Insider MITCHELL DEAN J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	648	$0.00	$0.00
Grant/Award	Common Stock	1,371	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 648 contracts (Direct); Common Stock — 18,622 shares (Direct)

Footnotes (2)

F1. Mr. Mitchell was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Key Figures

Restricted stock units granted: 1,371 units Common shares after RSU grant: 18,622 shares Stock options granted: 648 options +4 more

7 metrics

Restricted stock units granted 1,371 units Grant to J. Dean Mitchell on June 10, 2026

Common shares after RSU grant 18,622 shares Direct holdings following RSU award

Stock options granted 648 options Derivative grant on June 10, 2026

Option exercise price $240.66 per share Strike price for 648 stock options

Option expiration date June 10, 2036 Final expiration for granted options

RSU vesting date June 10, 2027 Or earlier 2027 annual stockholder meeting

Option vesting start July 10, 2026 First of twelve equal monthly installments

Key Terms

restricted stock units, Stock Option (Right to Buy), contingent right, vest in twelve (12) equal monthly installments, +1 more

5 terms

restricted stock units financial

"Mr. Mitchell was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" with 648.0000 shares underlying common stock..."

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."

vest in twelve (12) equal monthly installments financial

"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month..."

annual meeting of stockholders financial

"The restricted stock units vest on June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders, whichever is earlier."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did J. Dean Mitchell receive from Praxis Precision Medicines (PRAX)?

J. Dean Mitchell received 1,371 restricted stock units and stock options for 648 shares of Praxis common stock. The RSUs convert into common shares upon vesting, and the options allow future purchases at a fixed exercise price.

How do the 1,371 restricted stock units granted to PRAX director Mitchell vest?

The 1,371 restricted stock units vest in a single annual installment on the earlier of June 10, 2027 or the Praxis 2027 annual stockholder meeting. Once vested, they are settled only in shares of Praxis common stock, increasing his share ownership.

What are the key terms of the 648 Praxis stock options granted to Mitchell?

Mitchell’s 648 stock options have an exercise price of $240.66 per share and expire on June 10, 2036. They vest in twelve equal monthly installments beginning July 10, 2026 and ending on the earlier of June 10, 2027 or the 2027 annual stockholder meeting.

Are the restricted stock units granted to Mitchell settled in cash or stock?

The restricted stock units granted to Mitchell may be settled only by delivering shares of Praxis common stock. This stock-settlement feature is why the RSU grant is reported in the non-derivative Table 1, consistent with applicable SEC guidance for such awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/12/2026 - 05:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MITCHELL DEAN J

(Last)

(First)

(Middle)

C/O PRAXIS PRECISION MEDICINES, INC.

99 HIGH STREET, 30TH FLOOR

(Street)

BOSTON

MASSACHUSETTS

02110

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Praxis Precision Medicines, Inc. [ PRAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/10/2026		A⁽¹⁾		1,371	A	$0	18,622	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$240.66	06/10/2026		A		648		⁽²⁾	06/10/2036	Common Stock	648	$0	648	D

Explanation of Responses:

1. Mr. Mitchell was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Remarks:

	/s/ Alex Nemiroff, as Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Praxis director receives RSU and option grants

Rhea-AI Filing Summary

Positive

Negative